文献速递术前评估与围术期医学神经外科与老年麻醉

低温对表达I型兰尼碱受体p.R2509C突变小鼠恶性高热触发的影响

Influence of Hypothermia on Triggering of Malignant Hyperthermia in a Mouse Model Expressing Type I Ryanodine Receptor-p.R2509C.
PubMed 文献 · Anesth Analg · 2026-09-23

本研究在小鼠模型中探讨低温是否抑制恶性高热触发或仅延缓致命代谢级联。结果显示低温虽延长生存时间并掩盖心动过速,但所有突变小鼠仍发生恶性高热和心脏骤停,高碳酸血症和酸中毒为关键早期指标。

要点

  • 低温不能预防恶性高热触发或致死性,仅延缓临床进展
  • 低温下心动过速和体温升高可能被掩盖,需警惕高碳酸血症和酸中毒
  • 线粒体肿胀为超早期病理改变,提示肌肉损伤非单纯热损伤

核心结论

  • 低温延缓恶性高热临床进展但不预防触发或致死性。

研究设计与样本

  • 采用杂合p.R2509C敲入小鼠和野生型小鼠的肌管进行药理学敏感性评估,并在麻醉小鼠中于34°C或36°C直肠温度下暴露2.5%七氟烷进行在体比较。

主要发现

  • 与野生型肌管相比,R2509C肌管在30°C和40°C下咖啡因剂量反应曲线左移且半数有效浓度更低(30°C估计治疗效应=2.0 mM,95%CI 0.5-3.6 mM,P=.020;40°C估计治疗效应=2.1 mM,95%CI 0.5-3.7 mM,P=.029)。
  • 将肌管从36°C冷却至34°C显著降低R2509C肌管内相对细胞内Ca2+荧光。
  • 在体所有突变小鼠无论温度均发生恶性高热并心脏骤停,34°C下生存时间较36°C显著延长(平均差=45.0分钟,95%CI 20.9-69.1分钟,P=.002)。
  • 34°C下缺乏心动过速等典型体征,但仍出现进行性高碳酸血症、代谢性酸中毒、高钾血症和特征性线粒体肿胀。

临床怎么用

  • 临床应警惕低温可能掩盖心动过速和体温升高,高碳酸血症和酸中毒为关键早期指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although hyperthermia exacerbates the pathophysiology of malignant hyperthermia (MH), the response to hypothermia remains poorly understood. MH susceptible-swine studies suggested that hypothermia prevents MH, yet clinical cases occur during hypothermic cardiopulmonary bypass. This study aimed to elucidate whether hypothermia inhibits the MH trigger or merely decelerates the progression of the lethal metabolic cascade. METHODS: Pharmacological sensitivity of type 1 ryanodine receptor was evaluated in myotubes from heterozygous p.R2509C knock-in mice and wild-type (WT) mice by measuring the half-maximal effective concentration of caffeine at 30 °C and 40 °C. Intracellular calcium dynamics were also assessed during temperature changes. In vivo, anesthetized male and female mice were exposed to 2.5% sevoflurane at rectal temperatures of 34 °C or 36 °C. Survival time, heart rate, arterial blood gas analysis, and muscle ultrastructure were compared. RESULTS: Compared with WT myotubes, R2509C myotubes showed a leftward shift in the caffeine dose-response curve and a lower half-maximal effective concentration at both 30 °C (estimated treatment effects = 2.0 mM, 95% confidence interval [CI], 0.5-3.6 mM, P = .020) and 40 °C (estimated treatment effects = 2.1 mM, 95% CI, 0.5-3.7 mM, P = .029). Cooling myotubes from 36 °C to 34 °C significantly reduced relative intracellular Ca2+ fluorescence in R2509C myotubes. In vivo, all mutant mice developed MH and went into cardiac arrest regardless of temperature. Survival time was significantly longer at 34 °C compared to 36 °C (mean difference = 45.0 minutes, 95% CI, 20.9-69.1 minutes, P = .002). Typical signs such as tachycardia were absent at 34 °C. Despite masked clinical signs, progressive hypercapnia, metabolic acidosis, hyperkalemia, and characteristic mitochondrial swelling occurred in hypothermia. CONCLUSIONS: Hypothermia decelerates the clinical progression of MH but does not prevent triggering or lethality in mouse models. The caffeine-hypersensitivity of R2509C myotubes was detectable even under the lower-temperature assay condition. Mitochondrial swelling was identified as an ultra-early pathological change, suggesting that muscle damage is not solely driven by thermal injury. Clinicians should be aware that hypothermia may mask tachycardia and body temperature elevation, leaving hypercapnia and acidosis as critical early indicators.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Ikeda T, Mukaida K, Kido K, et al. Influence of Hypothermia on Triggering of Malignant Hyperthermia in a Mouse Model Expressing Type I Ryanodine Receptor-p.R2509C. Anesth Analg. 2026. PMID: 42775836. doi:10.1213/ANE.0000000000008333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。